ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.29% | -0.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.29% | -0.14% | |||
| Cost of Revenue | 2.27% | 1.59% | |||
| Gross Profit | 2.28% | -0.39% | |||
| SG&A Expenses | 2.28% | 1.85% | |||
| Depreciation & Amortization | 2.28% | 5.81% | |||
| Other Operating Expenses | 2.28% | -18.71% | |||
| Total Operating Expenses | 2.29% | 0.54% | |||
| Operating Income | -2.29% | -1.01% | |||
| Income Before Tax | -2.28% | -8.73% | |||
| Income Tax Expenses | 2.38% | -8.70% | |||
| Earnings from Continuing Operations | -2.28% | -8.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.28% | -8.71% | |||
| EBIT | -2.29% | -1.01% | |||
| EBITDA | -9.56% | -16.43% | |||
| EPS Basic | 0.00% | 0.00% | |||
| Normalized Basic EPS | -8.33% | 0.00% | |||
| EPS Diluted | 0.00% | 0.00% | |||
| Normalized Diluted EPS | -8.33% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 9.85% | |||
| Average Diluted Shares Outstanding | 0.00% | 9.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||